abrdn Life Sciences Investors
HQL
44 hedge funds and large institutions have $65M invested in abrdn Life Sciences Investors in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
9% more capital invested
Capital invested by funds: $59.6M → $65M (+$5.41M)
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less funds holding
Funds holding: 45 → 44 (-1)
2.23% less ownership
Funds ownership: 14.14% → 11.91% (-2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$6.29M |
| 2 |
Morgan Stanley
New York
|
+$2.11M |
| 3 |
UR
USCA RIA
Houston,
Texas
|
+$498K |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$487K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$376K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NIM
Needham Investment Management
New York
|
-$2.78M |
| 2 |
LPL Financial
San Diego,
California
|
-$1.59M |
| 3 |
DA
Doliver Advisors
Houston,
Texas
|
-$1.39M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$300K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$245K |
HQL Hedge Fund Activity: Q2 2015 in Review
44 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q2 2015, worth a combined $65M — up 9.1% from $59.6M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new HQL positions and 5 closed out — a net gain of 1 holder — while 15 added to existing stakes and 14 trimmed.
The largest buyer was Advisors Asset Management, opening a new position worth an estimated $6.29M. The largest seller was Needham Investment Management, cutting an estimated $2.78M.
- 44 institutional investors held abrdn Life Sciences Investors (HQL) as of Q2 2015, down from 45 in Q1 2015.
- Funds reported $65M of abrdn Life Sciences Investors stock for Q2 2015, up 9.1% quarter-over-quarter.
- 6 funds opened new abrdn Life Sciences Investors positions in Q2 2015 and 5 closed out, a net change of +1 holder.
- The largest abrdn Life Sciences Investors buyer in Q2 2015 was Advisors Asset Management, an estimated $6.29M added.
- The largest abrdn Life Sciences Investors seller in Q2 2015 was Needham Investment Management, an estimated $2.78M sold.
Based on aggregated 13F filings for Q2 2015.